Chemotherapy
237
58
62
73
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Research Maturity
73 completed trials (31% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.0%
7 terminated out of 237 trials
91.3%
+4.7% vs benchmark
9%
22 trials in Phase 3/4
3%
2 of 73 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 73 completed trials
Clinical Trials (237)
A Prospective, Biomarker-Stratified Phase 2 Study: β-Hydroxybutyrate as a Predictive Biomarker for Short-Course Radiotherapy Followed by Chemotherapy Plus PD-1 Inhibitor Versus Chemotherapy Alone in Locally Advanced Rectal Cancer
The Effect of the 4-7-8 Breathing Technique on Anxiety, Symptom Burden, and Sleep Quality During Chemotherapy
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
Chemotherapy-Induced Hearing Loss and Health Inequality
Effect of Gamified Sun Protection Education Provided to Chemotherapy Patients
Chemo Brain Prehab Project
Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma
RegisterPROS - A Registry for Prostate Cancers
Adjuvant Chemotherapy for High Malignant Prostate Cancer
Assessment of Adebelizumab Combined With Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone for Prevention of CINV in Breast Cancer Patients Receiving Highly Emetogenic Chemotherapy
Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy
Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer
The Effect of a Music-Assisted Mandala Intervention on Psychological Well-being and Quality of Life in Cancer Patients Undergoing Chemotherapy
Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC
Iparomlimab and Tuvonralimab (QL1706) Plus Lenvatinib and Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma
The Effect of a Virtual Reality-Based Mindfulness Intervention on Anxiety, Comfort, Sleep, and Fatigue in Breast Cancer Patients Undergoing Chemotherapy
Effect of AI-Assisted Expressive Writing on Anxiety, Emotional Distress, and Quality of Life Among Patients Receiving Chemotherapy
Quality of Life of Patients Who Have Undergone Bilateral Mastectomy
Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application